French Pharma Firm Sanofi to Acquire US-Based Blueprint Medicines for $9.1B
Paris: France-based pharmaceutical company Sanofi stated Monday that it will acquire US-based Blueprint Medicines Corporation for $9.1 billion to expand its portfolio in rare immunological diseases.
According to Anadolu Agency, Blueprint Medicines…